In: Sleep, 2016, vol. 39, no. 3, p. 581-587
|
In: Blood, 2020, vol. 137, no. 10, p. 1365–1376
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B cell receptor immunoglobulins (BcR IG). Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR IG stereotypy in CLL has important implications for understanding disease...
|
In: Haematologica, 2020, vol. 105, no. 2, p. 448-456
BIRC3 is a recurrently mutated gene in chronic lymphocytic leukemia (CLL) but the functional implications of BIRC3 mutations are largely unexplored. Furthermore, little is known about the prognostic impact of BIRC3 mutations in CLL cohorts homogeneously treated with first-line fludarabine, cyclophosphamide, and rituximab (FCR). By immunoblotting analysis, we showed that the non-canonical...
|
In: Plos pathogens, 2012, vol. 8, no. 2, p. e1002497
Herpes simplex virus (HSV) types 1 and 2 are highly prevalent human neurotropic pathogens that cause a variety of diseases, including lethal encephalitis. The relationship between HSV and the host immune system is one of the main determinants of the infection outcome. Chemokines play relevant roles in antiviral response and immunopathology, but the modulation of chemokine function by HSV is...
|
In: Energy Efficiency, 2014, vol. 7, no. 4, p. 571-590
|
In: Biological Invasions, 2012, vol. 14, no. 10, p. 2203-2215
|
In: Hydrogeology Journal, 2009, vol. 17, no. 1, p. 49-59
|
In: Sozial- und Präventivmedizin, 2002, vol. 47, no. 1, p. 48-58
|
In: Diabetologia, 2003, vol. 46, no. 11, p. 1581-1585
|
In: Diabetologia, 2008, vol. 51, no. 1, p. 91-100
|